|
Volumn 39, Issue 1, 2002, Pages 63-65
|
Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): Do outcomes differ from t(4;11)?
|
Author keywords
Acute lymphoblastic leukemia; ALL in infants; Translocation 11q23
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ARTICLE;
BONE MARROW BIOPSY;
BONE MARROW TRANSPLANTATION;
CASE REPORT;
CHROMOSOME 11Q;
CHROMOSOME ABERRATION;
CHROMOSOME TRANSLOCATION;
CLINICAL FEATURE;
CYTOGENETICS;
DISEASE COURSE;
FEMALE;
FLOW CYTOMETRY;
HUMAN;
IMMUNOPHENOTYPING;
INFANT;
KARYOTYPE;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
PROGNOSIS;
6-MERCAPTOPURINE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASPARAGINASE;
CHROMOSOMES, HUMAN, PAIR 11;
CHROMOSOMES, HUMAN, PAIR 4;
CYCLOPHOSPHAMIDE;
CYTARABINE;
CYTOGENETIC ANALYSIS;
DAUNORUBICIN;
DNA PRIMERS;
FEMALE;
HUMANS;
INFANT;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
METHOTREXATE;
PREDNISONE;
TRANSLOCATION, GENETIC;
VINCRISTINE;
|
EID: 0036109739
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/mpo.10047 Document Type: Article |
Times cited : (1)
|
References (23)
|